UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 13, 2010
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware
|
1-3619
|
13-5315170
|
(State or other Jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
10017
(Zip Code) |
Registrant's telephone number, including area code:
(212) 733-2323
Not Applicable
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
As reported in a Current Report on Form 8-K filed on December 9, 2010, the Board of Directors of Pfizer Inc. (the “Company”) elected Ian C. Read as President and Chief Executive Officer and as a member of the Board of Directors on December 5, 2010. In connection with Mr. Read’s promotion, on December 13, 2010, the Compensation Committee of the Board approved the following new compensation arrangements for Mr. Read effective January 1, 2011:
In addition, in connection with the assumption of increased responsibilities by Frank A. D’Amelio, Executive Vice President, Chief Financial Officer and Business Operations, on December 13, 2010, the Compensation Committee approved the following new compensation arrangements for Mr. D’Amelio effective January 1, 2011:
|
|
Item 8.01 | Other Events |
On December 13, 2010, the Board of Directors elected George A. Lorch, who has served as an independent director since 2000, as non-executive Chairman of the Board. Mr. Lorch relinquished his positions as Chair and a member of the Board’s Compensation Committee and as a member of the Board’s Science and Technology Committee in order to focus on his role as Chairman. |
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits |
||
Exhibit No. | Description | |
99.1 | Press Release dated December 13, 2010 | |
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC.
|
||
By: /s/ Matthew Lepore
Matthew Lepore |
||
Title: Vice President and Corporate Secretary |
||
Dated: December 16, 2010 |
EXHIBIT INDEX
Number |
Description |
99.1 | Press Release dated December 13, 2010 |